Prosight Management, LP Ab Cellera Biologics Inc. Transaction History
Prosight Management, LP
- $337 Million
- Q4 2024
A detailed history of Prosight Management, LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Prosight Management, LP holds 7,350,000 shares of ABCL stock, worth $22.3 Million. This represents 6.4% of its overall portfolio holdings.
Number of Shares
7,350,000
Previous 9,079,539
19.05%
Holding current value
$22.3 Million
Previous $23.5 Million
8.42%
% of portfolio
6.4%
Previous 6.31%
Shares
10 transactions
Others Institutions Holding ABCL
# of Institutions
166Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$83.4 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$37.1 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$32.2 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$24 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$13.8 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $864M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...